![Lynette Herscha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lynette Herscha
Direttore operativo presso
Immunitas Therapeutics, Inc.
Profilo
Lynette Herscha is currently the Chief Operating Officer at Immunitas Therapeutics, Inc. She previously worked as the Secretary & General Counsel at Concert Pharmaceuticals, Inc. from 2017 to 2019.
She also held the position of Secretary & Chief Legal Officer at Solid Biosciences, Inc. Ms. Herscha received her undergraduate degree from Boston University and her graduate degree from Boston University School of Law.
Posizioni attive di Lynette Herscha
| Società | Posizione | Inizio |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Direttore operativo | 13/07/2022 |
Precedenti posizioni note di Lynette Herscha
| Società | Posizione | Fine |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Consigliere Generale | 01/01/2019 |
| SOLID BIOSCIENCES INC. | Consigliere Generale | - |
Formazione di Lynette Herscha
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
